Application Version: 4.0.6.10
Content Version: 2024.07.12
Release Notes [PDF288KB]
User Guide [PDF6.08MB]
Code System Update Calendar
Contact Us
Subscribe
Related Links
- PHIN Vocabulary Services
- Quick Links / Mapping Tools
- External Standards Resources
- Message Guides
- Developer's Guide
- PHINVADS FHIR API
Downloads
- RCMT Quick Search
Value Set Information
|
- Value Set Concepts
- Value Set Details
|
||||||
Concept Code | Concept Name | Preferred Concept Name | Code System | Value Set | ||
---|---|---|---|---|---|---|
24 | anthrax | anthrax vaccine | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
181 | anthrax immune globulin | anthrax immune globulin | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
19 | BCG | Bacillus Calmette-Guerin vaccine | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
27 | botulinum antitoxin | botulinum antitoxin | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
173 | cholera, BivWC | cholera, BivWC | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
174 | cholera, live attenuated | cholera, live attenuated | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
26 | cholera, unspecified formulation | cholera vaccine, unspecified formulation | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
172 | cholera, WC-rBS | cholera, WC-rBS | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
516 | COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) | SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
510 | COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
502 | COVID-19 IV Non-US Vaccine (COVAXIN) | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
211 | COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL | Vaccines administered (CVX) | Vaccine Type (NND) | Details | |
210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL | Vaccines administered (CVX) | Vaccine Type (NND) | Details |
- Page last reviewed:June 20, 2024
- Page last updated:June 20, 2024
- Content source: